Trials / Completed
CompletedNCT03239613
Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer
Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_CCRT Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by concurrent chemotherapy with hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.
Conditions
- Cervix Cancer
- Radiotherapy, Adjuvant
- Radiotherapy, Intensity-Modulated
- Hypofractionated Dose
- Chemotherapy, Concurrent
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | POHIM-CCRT | postoperative adjuvant concurrent chemotherapy with hypofractionated IMRT (2.5 Gy/fraction, 16 fractions, once a day) |
Timeline
- Start date
- 2017-08-31
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2017-08-04
- Last updated
- 2025-01-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03239613. Inclusion in this directory is not an endorsement.